MiGenTra GmbH
Dina Soliman serves as the Director of Strategic Operations and Business Development at Minapharm Pharmaceuticals since November 2014 and also holds the position of Business Board Member at MiGenTra GmbH since October 2021. Prior experience includes founding and managing Le Palmier Bebe French Nurseries from April 2010 to June 2014 and working as a CS MEAF Team Coach at Dow from February 2007 to May 2009. Earlier roles at Minapharm Pharmaceuticals as a Senior Planning Coordinator spanned from February 1997 to February 2004. Dina Soliman holds a Master's degree in Business Information Technology with a focus on Artificial Intelligence from Middlesex University and a Bachelor of Science in Chemistry from The American University in Cairo. Early education was completed at College du Sacre-Coeur.
This person is not in any teams
This person is not in any offices
MiGenTra GmbH
MiGenTra is a healthcare transforming medicines company, and a subsidiary of ProBioGen, with a focus on high quality medicines at affordable prices. The company allows for product development in the field of Biosimilars, Cell and Gene Therapies and vaccines especially for Egypt, the Middle East and Africa, and will therefore provide access to key healthcare transforming medicines, while strengthening regional and local manufacturing capacity in the region. MiGenTra combines scientific and manufacturing subject matter expertise from both contributing companies, ProBioGen and Minapharm Pharmaceuticals and is headquartered in Berlin, Germany and has access to a site in Cairo, Egypt, where the main manufacturing plant is located.